000 | 01925 a2200565 4500 | ||
---|---|---|---|
005 | 20250517194314.0 | ||
264 | 0 | _c20180323 | |
008 | 201803s 0 0 eng d | ||
022 | _a1873-2550 | ||
024 | 7 |
_a10.1016/j.vetpar.2017.12.005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCastro, R S | |
245 | 0 | 0 |
_aHepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol. _h[electronic resource] |
260 |
_bVeterinary parasitology _cJan 2018 |
||
300 |
_a22-29 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAllopurinol _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntiprotozoal Agents _xpharmacology |
650 | 0 | 4 |
_aDog Diseases _xdrug therapy |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aLeishmania infantum |
650 | 0 | 4 |
_aLeishmaniasis, Visceral _xcomplications |
650 | 0 | 4 |
_aLiposomes _xadministration & dosage |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 |
_aLiver Cirrhosis _xetiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMeglumine _xpharmacology |
650 | 0 | 4 | _aMeglumine Antimoniate |
650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacology |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aTransforming Growth Factor beta _xgenetics |
650 | 0 | 4 |
_aVimentin _xgenetics |
700 | 1 | _ade Amorim, I F G | |
700 | 1 | _aPereira, R A | |
700 | 1 | _aSilva, S M | |
700 | 1 | _aPinheiro, L J | |
700 | 1 | _aPinto, A J W | |
700 | 1 | _aAzevedo, E G | |
700 | 1 | _aDemicheli, C | |
700 | 1 | _aCaliari, M M V | |
700 | 1 | _aMosser, D M | |
700 | 1 | _aMichalick, M S M | |
700 | 1 | _aFrezard, Frédéric J G | |
700 | 1 | _aTafuri, Wagner L | |
773 | 0 |
_tVeterinary parasitology _gvol. 250 _gp. 22-29 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vetpar.2017.12.005 _zAvailable from publisher's website |
999 |
_c27975650 _d27975650 |